Unknown

Dataset Information

0

LVEF by Multigated Acquisition Scan Compared to Other Imaging Modalities in Cardio-Oncology: a Systematic Review.


ABSTRACT:

Purpose of review

The prevalence of cancer therapy-related cardiac dysfunction (CTRCD) is increasing due to improved cancer survival. Serial monitoring of cardiac function is essential to detect CTRCD, guiding timely intervention strategies. Multigated radionuclide angiography (MUGA) has been the main screening tool using left ventricular ejection fraction (LVEF) to monitor cardiac dysfunction. However, transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging (CMR) may be more suitable for serial assessment. We aimed to assess the concordance between different non-radiating imaging modalities with MUGA to determine whether they can be used interchangeably.

Recent findings

In order to identify relevant studies, a PubMed search was performed. We included cross-sectional studies comparing MUGA LVEF to that of 2D TTE, 3D TTE, and CMR. From 470 articles, 22 were selected, comprising 1017 patients in total. Among others, this included three 3D TTE, seven 2D harmonic TTE + contrast (2DHC), and seven CMR comparisons. The correlations and Bland-Altman limits of agreement varied for CMR but were stronger for 3D TTE and 2DHC. Our findings suggest that MUGA and CMR should not be used interchangeably whereas 3D TTE and 2DHC are appropriate alternatives following an initial MUGA scan. We propose a multimodality diagnostic imaging strategy for LVEF monitoring in patients undergoing cancer treatment.

SUBMITTER: Printezi MI 

PROVIDER: S-EPMC9177497 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

LVEF by Multigated Acquisition Scan Compared to Other Imaging Modalities in Cardio-Oncology: a Systematic Review.

Printezi Markella I MI   Yousif Laura I E LIE   Kamphuis Janine A M JAM   van Laake Linda W LW   Cramer Maarten J MJ   Hobbelink Monique G G MGG   Asselbergs Folkert W FW   Teske Arco J AJ  

Current heart failure reports 20220330 3


<h4>Purpose of review</h4>The prevalence of cancer therapy-related cardiac dysfunction (CTRCD) is increasing due to improved cancer survival. Serial monitoring of cardiac function is essential to detect CTRCD, guiding timely intervention strategies. Multigated radionuclide angiography (MUGA) has been the main screening tool using left ventricular ejection fraction (LVEF) to monitor cardiac dysfunction. However, transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging (CMR) may  ...[more]

Similar Datasets

| S-EPMC8352045 | biostudies-literature
| S-EPMC5558528 | biostudies-other
| S-EPMC9823145 | biostudies-literature
| S-EPMC5544812 | biostudies-other
| S-EPMC4869978 | biostudies-literature
| S-EPMC6811998 | biostudies-literature
| S-EPMC8452206 | biostudies-literature
| S-EPMC6402516 | biostudies-literature
| S-EPMC7325299 | biostudies-literature
| S-EPMC10300834 | biostudies-literature